CVS Health Ventures

As #value #based care continues to be a key theme in health care, CVS Health Ventures portfolio company Thyme Care is leaning into this shift in care mentality. #Cancer care faces many challenges, from rising costs, to fragmented and decentralized services, as well as having a significant emotional toll on patients. Value based care offers an opportunity to streamline the experience for the patient, leading to improved outcomes overall. Learn more here: https://lnkd.in/dzmXKs94

We’re delighted to announce our newest investment in Nema Health! Nema is a digital mental health startup focused on treating and managing post traumatic stress disorder (PTSD). While #PTSD is commonly thought of as only affecting combat veterans, it is often underdiagnosed and untreated in #women at large. Nema Health offers a multipronged approach of CPT-based talk therapy, medication management, and peer support to help treat patients suffering from PTSD. Getting treatment in the form of comprehensive, specialized #trauma therapy is often critical to recovery, and we are proud to support a company at the forefront of supporting those seeking to manage PTSD. Learn more here: https://lnkd.in/eHg-qexk

Excited to see portfolio company Monogram Health named in the Nashville Business Journal’s Power 100 Disruptors. As a company with both local and national presence in the chronic care space, Monogram continues to be recognized for its many accomplishments Learn more here: https://lnkd.in/ewdwcZ4a

Portfolio company Cortica has closed a strategic round! This latest round of funding is intended to support value-based contracting and continuing to integrate tools focused on faster evaluation, diagnosis, and treatment. It’s always exciting to see the growth and development of a portfolio company. Learn more here: https://lnkd.in/eNwFSWD8

We are pleased to announce an investment in our newest portfolio company, Synapticure Inc.! Synapticure is focused on support care and treatment of individuals living with dementia, Parkinson’s, ALS, and other #neurodegenerative diseases. CVS Health Ventures’ investment aims to support Synapticure’s innovative and proprietary technology. Their AI-enabled platform allows for advanced analytics, informing clinical research and accelerating diagnoses and access to treatment. We’re proud to be a part of this exciting work moving forward. Learn more here: https://lnkd.in/gWZH37yn

In a recent episode of the podcast “The Autism Dad,” portfolio company co-founder Dr. Suzanne Goh spoke about the role that pediatric neurologists play in #autism diagnosis, and how caregivers can better advocate for neurodivergent children. Learn more here: https://lnkd.in/ehmM-SHR

CVS Health Ventures portfolio company, Waymark, has recently published a new study in the New England Journal of Medicine demonstrating a 22.9% reduction in ER and hospital visits. A Medicaid focused company, Waymark supports data-enabled, #community health worker based interventions for at-risk patients that have now been shown to significantly reduce the need for emergency care. Their proprietary #algorithm has a measured accuracy of greater than 90%, which allows for better opportunities to reach out to patients in need, and also facilitates #continuity of care when hospital interventions are needed, leading to improved outcomes. Learn more here: https://lnkd.in/eY-e8dWS

Great news for our portfolio company Oshi Health, which recently raised a Series C round! This funding will help support Oshi’s continued growth as it emerges as a leader in #virtual #digestive care, enabling expansion into new partnerships including employers and #Medicare populations in 2025. We are excited to continue our work. Learn more here: https://lnkd.in/ekhujU_B

Always delighted to see our portfolio companies recognized in trade publications. This year’s Inc 5000 list has identified the fastest growing private companies in America, and the 2024 cohort includes companies such as Monogram Health and Workit Health. We’re proud to support these companies along their growth journey. To learn more about the Inc 5000 list, read here: https://lnkd.in/g6Yn3rnH

Thirty Madison, a CVS Health Ventures portfolio company, recently published the results of a survey aimed at understanding about how #women are perceiving the current healthcare environment. Of note, they found that 37% of women are now turning to telehealth to access care – emphasizing the value proposition of digital health solutions within this care segment. Learn more here: https://lnkd.in/g99UaujT